Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.

Altenburg JD, Bieberich AA, Terry C, Harvey KA, Vanhorn JF, Xu Z, Jo Davisson V, Siddiqui RA.

BMC Cancer. 2011 Apr 21;11:149. doi: 10.1186/1471-2407-11-149.

2.

Characterization of synergistic anti-cancer effects of docosahexaenoic acid and curcumin on DMBA-induced mammary tumorigenesis in mice.

Siddiqui RA, Harvey KA, Walker C, Altenburg J, Xu Z, Terry C, Camarillo I, Jones-Hall Y, Mariash C.

BMC Cancer. 2013 Sep 13;13:418. doi: 10.1186/1471-2407-13-418.

3.

Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.

Rescigno T, Capasso A, Tecce MF.

J Cell Physiol. 2016 Jun;231(6):1226-36. doi: 10.1002/jcp.25217.

PMID:
26480024
5.

Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.

Siddiqui RA, Harvey KA, Xu Z, Natarajan SK, Davisson VJ.

Bioorg Med Chem. 2014 Mar 15;22(6):1899-908. doi: 10.1016/j.bmc.2014.01.051.

PMID:
24556504
6.
7.

Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.

Zhou QM, Chen QL, Du J, Wang XF, Lu YY, Zhang H, Su SB.

Int J Mol Sci. 2014 Sep 15;15(9):16284-301. doi: 10.3390/ijms150916284.

8.

Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis.

Wang F, Bhat K, Doucette M, Zhou S, Gu Y, Law B, Liu X, Wong ET, Kang JX, Hsieh TC, Qian SY, Wu E.

Curr Mol Med. 2011 Aug;11(6):503-11.

9.

Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells.

Ewaschuk JB, Newell M, Field CJ.

Lipids. 2012 Nov;47(11):1019-30. doi: 10.1007/s11745-012-3717-7.

PMID:
23054549
10.

Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells.

Rovito D, Giordano C, Vizza D, Plastina P, Barone I, Casaburi I, Lanzino M, De Amicis F, Sisci D, Mauro L, Aquila S, Catalano S, Bonofiglio D, Andò S.

J Cell Physiol. 2013 Jun;228(6):1314-22. doi: 10.1002/jcp.24288.

PMID:
23168911
11.

Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.

Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP, Darzynkiewicz Z.

Cancer Res. 2000 Aug 1;60(15):4139-45.

12.
13.

Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells.

Pogash TJ, El-Bayoumy K, Amin S, Gowda K, de Cicco RL, Barton M, Su Y, Russo IH, Himmelberger JA, Slifker M, Manni A, Russo J.

In Vitro Cell Dev Biol Anim. 2015 Feb;51(2):121-7. doi: 10.1007/s11626-014-9822-6.

15.

PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.

Tuller ER, Brock AL, Yu H, Lou JR, Benbrook DM, Ding WQ.

Biochem Pharmacol. 2009 May 1;77(9):1480-6. doi: 10.1016/j.bcp.2009.02.002.

PMID:
19426685
16.

[Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway].

Lin YJ, Huang YH, Zhen YZ, Liu XJ, Zhen YS.

Yao Xue Xue Bao. 2008 Nov;43(11):1099-105. Chinese.

PMID:
19239027
18.

Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.

Harvey KA, Xu Z, Saaddatzadeh MR, Wang H, Pollok K, Cohen-Gadol AA, Siddiqui RA.

J Neurosurg. 2015 Mar;122(3):547-56. doi: 10.3171/2014.10.JNS14759.

PMID:
25526274
19.
20.

Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).

Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ.

Mol Cancer. 2015 Jul 16;14:133. doi: 10.1186/s12943-015-0400-7.

Items per page

Supplemental Content

Support Center